{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:38:58Z","timestamp":1776944338562,"version":"3.51.4"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Access Publication Funds of the Gottingen University"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ijcard.2017.03.154","type":"journal-article","created":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T23:32:05Z","timestamp":1491089525000},"page":"12-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Animal models of cachexia and sarcopenia in chronic illness: Cardiac function, body composition changes and therapeutic results"],"prefix":"10.1016","volume":"238","author":[{"given":"Junichi","family":"Ishida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfram","family":"Doehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Springer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2017.03.154_bb0005","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0010","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \u201ccachexia-anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics\u201d","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0020","doi-asserted-by":"crossref","first-page":"990S","DOI":"10.1093\/jn\/127.5.990S","article-title":"Sarcopenia: origins and clinical relevance","volume":"127","author":"Rosenberg","year":"1997","journal-title":"J. Nutr."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0025","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1152\/jappl.1977.43.6.1001","article-title":"Effect of muscle mass decrease on age-related BMR changes","volume":"43","author":"Tzankoff","year":"1977","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0026-0495(70)90062-4","article-title":"Adult lean body mass declines with age: some longitudinal observations","volume":"19","author":"Forbes","year":"1970","journal-title":"Metabolism"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0035","doi-asserted-by":"crossref","first-page":"M772","DOI":"10.1093\/gerona\/57.12.M772","article-title":"Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women","volume":"57","author":"Iannuzzi-Sucich","year":"2002","journal-title":"J. Gerontol. Ser. A Biol. Med. Sci."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13539-014-0164-8","article-title":"Prevalence, incidence and clinical impact of cachexia: facts and numbers\u2014update 2014","volume":"5","author":"von Haehling","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0045","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ejhf.240","article-title":"Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials","volume":"17","author":"Rossignol","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0050","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ejhf.489","article-title":"Body mass index in acute heart failure: association with clinical profile, therapeutic management and in-hospital outcome","volume":"18","author":"Parissis","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-010-0002-6","article-title":"Cachexia as a major underestimated and unmet medical need: facts and numbers","volume":"1","author":"von Haehling","year":"2010","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0060","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJMcibr1106880","article-title":"Cancer cachexia and fat\u2013muscle physiology","volume":"365","author":"Fearon","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jcsm.12010","article-title":"Understanding and managing cancer-related weight loss and anorexia: insights from a systematic review of qualitative research","volume":"6","author":"Cooper","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jcsm.12059","article-title":"Pathophysiology of anorexia in the cancer cachexia syndrome","volume":"6","author":"Ezeoke","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0075","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00520-010-0972-0","article-title":"Animal models of the cancer anorexia\u2013cachexia syndrome","volume":"19","author":"Bennani-Baiti","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0085","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/ejhf.317","article-title":"Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction","volume":"17","author":"Scherbakov","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0090","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0095","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/thx.2007.085456","article-title":"Prevalence, severity and underdiagnosis of COPD in the primary care setting","volume":"63","author":"Bednarek","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0100","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ejhf.110","article-title":"Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion","volume":"16","author":"van Riet","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0105","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/ejhf.400","article-title":"Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)","volume":"17","author":"Steinbeck","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcsm.12033","article-title":"Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients","volume":"6","author":"Lerner","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jcsm.12088","article-title":"Cachexia: a nutritional syndrome?","volume":"6","author":"Anker","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s13539-014-0128-z","article-title":"Patients' rationale for declining participation in a cancer-associated weight loss study","volume":"5","author":"Wanger","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/abbi.1993.1479","article-title":"Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals","volume":"306","author":"Tessitore","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0304-3835(98)00137-2","article-title":"Protein turnover in skeletal muscle of tumour-bearing transgenic mice overexpressing the soluble TNF receptor-1","volume":"130","author":"Llovera","year":"1998","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0135","first-page":"5919","article-title":"Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host","volume":"47","author":"Beck","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0140","first-page":"2290","article-title":"Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice","volume":"50","author":"Tanaka","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0145","first-page":"787","article-title":"Tentative identification of the toxohormones of cancer cachexia: roles of vasopressin, prostaglandin E2 and cachectin-TNF","volume":"20","author":"Siddiqui","year":"1989","journal-title":"Biochem. Int."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.semcdb.2015.09.002","article-title":"Experimental cancer cachexia: evolving strategies for getting closer to the human scenario","volume":"54","author":"Penna","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0155","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00520-010-0972-0","article-title":"Animal models of the cancer anorexia\u2013cachexia syndrome","volume":"19","author":"Bennani-Baiti","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1677\/JOE-09-0397","article-title":"Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failure","volume":"206","author":"Scarlett","year":"2010","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0165","first-page":"R1325","article-title":"Aortic banding in rat as a model to investigate malnutrition associated with heart failure","volume":"288","author":"H\u00e9li\u00e8s-Toussaint","year":"2005","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0170","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10741-012-9305-3","article-title":"Rodent models of heart failure: an updated review","volume":"18","author":"Gomes","year":"2013","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0175","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijcard.2011.07.056","article-title":"Analysis of liver metabolism in a rat model of heart failure","volume":"161","author":"Kato","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0180","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.ajpath.2011.01.005","article-title":"PGC-1\u03b1 promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice","volume":"178","author":"Geng","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0185","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1152\/japplphysiol.90884.2008","article-title":"Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia","volume":"105","author":"Steffen","year":"2008","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0190","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2353\/ajpath.2007.060505","article-title":"Oxidative phenotype protects myofibers from pathological insults induced by chronic heart failure in mice","volume":"170","author":"Li","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0195","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijcard.2009.01.060","article-title":"The influence of age and sex on disease development in a novel animal model of cardiac cachexia","volume":"133","author":"Palus","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0200","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1054\/bjoc.2001.1696","article-title":"Activation of Ca2+-dependent proteolysis in skeletal muscle and heart in cancer cachexia","volume":"84","author":"Costelli","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0205","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/eht302","article-title":"Prevention of liver cancer cachexia-induced cardiac wasting and heart failure","volume":"35","author":"Springer","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0210","first-page":"347","article-title":"Cardiac alterations in cancer-induced cachexia in mice","volume":"37","author":"Tian","year":"2010","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0215","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13539-013-0116-8","article-title":"Disruption of pro-oxidant and antioxidant systems with elevated expression of the ubiquitin proteosome system in the cachectic heart muscle of nude mice","volume":"4","author":"Hinch","year":"2013","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0220","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/0008-5472.CAN-10-3145","article-title":"Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner","volume":"71","author":"Cosper","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0225","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/ejhf.171","article-title":"Sex-dependent regulation of fibrosis and inflammation in human left ventricular remodelling under pressure overload","volume":"16","author":"Kararigas","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0230","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ejhf.15","article-title":"Sex differences in cardiomyopathies","volume":"16","author":"Meyer","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0235","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jnci\/djr556","article-title":"Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis","volume":"104","author":"Baldwin","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0240","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jcsm.12127","article-title":"A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European palliative care research centre cachexia project","volume":"8","author":"Cuhls","year":"2017","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0245","first-page":"3604","article-title":"Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid","volume":"61","author":"Whitehouse","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0250","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/sj.bjc.6604905","article-title":"Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice","volume":"100","author":"Van Norren","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0255","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1634\/theoncologist.2009-0153","article-title":"Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia","volume":"15","author":"Mantovani","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0260","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/jcpt.12059","article-title":"Application of the STOPP\/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact","volume":"38","author":"Hill-Taylor","year":"2013","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0265","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijcard.2008.06.094","article-title":"No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure","volume":"137","author":"Akashi","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0270","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jcsm.12063","article-title":"Evidence for partial pharmaceutical reversal of the cancer anorexia-cachexia syndrome: the case of anamorelin","volume":"6","author":"Anker","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0275","article-title":"Megestrol acetate for treatment of anorexia-cachexia syndrome","author":"Berenstein","year":"2005","journal-title":"Cochrane Libr"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0280","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/jcsm.12116","article-title":"Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation","volume":"7","author":"Musolino","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0285","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jpainsymman.2005.11.014","article-title":"Uric acid as a prognostic factor for survival time: a prospective cohort study of terminally ill cancer patients","volume":"31","author":"Shin","year":"2006","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0290","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/eurjhf\/hft132","article-title":"Uric acid and risk of heart failure: a systematic review and meta-analysis","volume":"16","author":"Huang","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0295","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/ejhf.419","article-title":"Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the high-risk myocardial infarction database initiative","volume":"17","author":"von Lueder","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0300","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/ijc.27494","article-title":"Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia","volume":"131","author":"Springer","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0305","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/jcsm.12017","article-title":"Febuxostat improves outcome in a rat model of cancer cachexia","volume":"6","author":"Konishi","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0310","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.rmed.2007.09.011","article-title":"Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary disease","volume":"102","author":"Berger","year":"2008","journal-title":"Respir. Med."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0315","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1158\/0008-5472.CAN-04-0425","article-title":"Anticachectic effects of formoterol a drug for potential treatment of muscle wasting","volume":"64","author":"Busquets","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0320","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3892\/ol.2011.442","article-title":"Formoterol treatment down-regulates the myostatin system in skeletal muscle of cachectic tumour-bearing rats","volume":"3","author":"Busquets","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0325","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s13539-014-0153-y","article-title":"Formoterol in the treatment of experimental cancer cachexia: effects on heart function","volume":"5","author":"Toledo","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0330","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0335","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.bbrc.2009.12.123","article-title":"Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia","volume":"391","author":"Benny Klimek","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0340","first-page":"R716","article-title":"Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice","volume":"301","author":"Murphy","year":"2011","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0345","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0090-4295(98)00348-3","article-title":"Dramatic rise in prostate-specific antigen after androgen replacement in a hypogonadal man with occult adenocarcinoma of the prostate","volume":"53","author":"Curran","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0350","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ncpendmet0120","article-title":"Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging","volume":"2","author":"Bhasin","year":"2006","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0355","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","article-title":"Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial","volume":"14","author":"Dobs","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0360","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2217\/fon.09.106","article-title":"Nonsteroidal selective androgen receptor modulator Ostarine\u2122 in cancer cachexia","volume":"5","author":"Zilbermint","year":"2009","journal-title":"Future Oncol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0365","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1016\/j.ijcard.2013.04.150","article-title":"Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia","volume":"168","author":"Palus","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0370","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jcsm.12126","article-title":"Espindolol for the treatment and prevention of cachexia in patients with stage III\/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial)","volume":"7","author":"Stewart Coats","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0375","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1001\/jamainternmed.2016.1548","article-title":"Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults","volume":"176","author":"Moore","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0380","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/ejhf.37","article-title":"Cardiorespiratory fitness and risk of heart failure: a population-based follow-up study","volume":"16","author":"Khan","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0385","first-page":"1409","article-title":"American College of Sports Medicine roundtable on exercise guidelines for cancer survivors","author":"PANEL E","year":"2010","journal-title":"J. ACSM"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0390","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ejhf.271","article-title":"ExtraHF survey: the first European survey on implementation of exercise training in heart failure patients","volume":"17","author":"Piepoli","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0395","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ejhf.101","article-title":"Effects of exercise training on depression in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Tu","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0400","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/ejhf.409","article-title":"Functional electrical stimulation of lower limb muscles as an alternative mode of exercise training in chronic heart failure: practical considerations and proposed algorithm","volume":"17","author":"Parissis","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0405","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ejhf.239","article-title":"Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle","volume":"17","author":"Bowen","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0410","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jcsm.12055","article-title":"Exercise for cancer cachexia in adults: executive summary of a Cochrane collaboration systematic review","volume":"6","author":"Grande","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0415","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.nut.2013.12.005","article-title":"Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia","volume":"30","author":"Trobec","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0420","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jcsm.12054","article-title":"Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling","volume":"7","author":"Chen","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0425","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ejhf.270","article-title":"Ribonucleotide reductase-mediated increase in dATP improves cardiac performance via myosin activation in a large animal model of heart failure","volume":"17","author":"Kadota","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0430","series-title":"Sarcopenia\u2013age-Related Muscle Wasting and Weakness: Mechanisms and Treatments","author":"Lynch","year":"2010"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0435","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s13539-011-0052-4","article-title":"Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass","volume":"3","author":"Sakuma","year":"2012","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0440","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jamda.2011.04.014","article-title":"Sarcopenia with limited mobility: an international consensus","volume":"12","author":"Morley","year":"2011","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0445","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jcsm.12079","article-title":"Rapid screening for sarcopenia","volume":"6","author":"Morley","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0450","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jcsm.12051","article-title":"Biomarkers for physical frailty and sarcopenia: state of the science and future developments","volume":"6","author":"Calvani","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0455","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/jcsm.12049","article-title":"Prevalence of sarcopenia among community-dwelling elderly of a medium-sized South American city: results of the COMO VAI? Study","volume":"7","author":"Barbosa-Silva","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0460","first-page":"afs173","article-title":"Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohort","author":"van Kan","year":"2012","journal-title":"Age Ageing"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2013.03.019","article-title":"Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study","volume":"14","author":"Lee","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0470","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jgs.12129","article-title":"Sarcopenia prevalence and associated factors in an elderly Taiwanese metropolitan population","volume":"61","author":"Lin","year":"2013","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0475","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ageing\/afs197","article-title":"Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS)","volume":"42","author":"Patel","year":"2013","journal-title":"Age Ageing"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0480","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/13685538.2010.489130","article-title":"Prevalence of sarcopenia and its association with functional and nutritional status among male residents in a nursing home in Turkey","volume":"13","author":"Bahat","year":"2010","journal-title":"Aging Male"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0485","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jcsm.12095","article-title":"Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the model for end-stage liver disease score","volume":"8","author":"Kalafateli","year":"2017","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0490","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jcsm.12039","article-title":"Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis","volume":"7","author":"Montano-Loza","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0495","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1152\/jappl.1991.71.2.644","article-title":"A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women","volume":"71","author":"Frontera","year":"1991","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0500","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1249\/00005768-199404000-00006","article-title":"Skeletal muscle weakness in old age: underlying mechanisms","volume":"26","author":"Brooks","year":"1994","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0505","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13539-013-0125-7","article-title":"The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats","volume":"5","author":"P\u00f6tsch","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0510","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1159\/000360289","article-title":"Diet-induced and age-related changes in the quadriceps muscle: MRI and MRS in a rat model of sarcopenia","volume":"60","author":"Fellner","year":"2014","journal-title":"Gerontology"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0515","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10522-012-9405-4","article-title":"Sarcopenia in the aging high-fat fed rat: a pilot study for modeling sarcopenic obesity in rodents","volume":"13","author":"Bollheimer","year":"2012","journal-title":"Biogerontology"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0520","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jcsm.12019","article-title":"Gender-specific differences in the development of sarcopenia in the rodent model of the ageing high-fat rat","volume":"6","author":"Kob","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0525","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1532-5415.2011.03534.x","article-title":"Cardiac structure and function and dependency in the oldest old","volume":"59","author":"Leibowitz","year":"2011","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0530","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jcsm.12043","article-title":"Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training","volume":"6","author":"Bowen","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0535","article-title":"Progressive resistance strength training for improving physical function in older adults","author":"Liu","year":"2009","journal-title":"Cochrane Libr"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0540","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jamda.2012.07.005","article-title":"Protein supplementation improves physical performance in frail elderly people: a randomized, double-blind, placebo-controlled trial","volume":"13","author":"Tieland","year":"2012","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0545","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/jcsm.12094","article-title":"Impact of creatine supplementation in combination with resistance training on lean mass in the elderly","volume":"7","author":"Pinto","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0550","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jcsm.12024","article-title":"Behavioural changes are a major contributing factor in the reduction of sarcopenia in caloric-restricted ageing mice","volume":"6","author":"van Norren","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0555","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/gerona\/glp068","article-title":"Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice","volume":"64","author":"LeBrasseur","year":"2009","journal-title":"J. Gerontol. Ser. A Biol. Med. Sci."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0560","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1152\/japplphysiol.01183.2010","article-title":"Acute antibody-directed myostatin inhibition attenuates disuse muscle atrophy and weakness in mice","volume":"110","author":"Murphy","year":"2011","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0565","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1210\/jc.2009-1251","article-title":"Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study","volume":"95","author":"Srinivas-Shankar","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0570","doi-asserted-by":"crossref","first-page":"M266","DOI":"10.1093\/gerona\/56.5.M266","article-title":"Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels","volume":"56","author":"Kenny","year":"2001","journal-title":"J. Gerontol. Ser. A Biol. Med. Sci."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0575","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13539-011-0034-6","article-title":"The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial","volume":"2","author":"Dalton","year":"2011","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0580","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jcsm.12097","article-title":"Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine","volume":"7","author":"Ferraro","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0585","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.phrs.2011.01.003","article-title":"Trimetazidine improves exercise performance in patients with peripheral arterial disease","volume":"63","author":"Vitale","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0590","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1152\/ajpendo.00083.2005","article-title":"Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy","volume":"290","author":"Monti","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2017.03.154_bb0595","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/jcsm.12136","article-title":"ACT-ONE \u2014 ACTION at last on cancer cachexia by adapting a novel action beta-blocker","volume":"7","author":"Lainscak","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0600","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/ageing\/afn124","article-title":"ACE inhibitors for sarcopenia\u2014as good as exercise training?","volume":"37","author":"Witham","year":"2008","journal-title":"Age Ageing"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0605","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(02)08024-8","article-title":"Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study","volume":"359","author":"Onder","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.03.154_bb0610","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1503\/cmaj.061339","article-title":"Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial","volume":"177","author":"Sumukadas","year":"2007","journal-title":"Can. Med. Assoc. J."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731732065X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731732065X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T10:22:48Z","timestamp":1568974968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752731732065X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":122,"alternative-id":["S016752731732065X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.03.154","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models of cachexia and sarcopenia in chronic illness: Cardiac function, body composition changes and therapeutic results","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.03.154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}